| Early detection of prostate cancer: AUA Guideline HB Carter, PC Albertsen, MJ Barry, R Etzioni, SJ Freedland, KL Greene, ... The Journal of urology 190 (2), 419-426, 2013 | 1478 | 2013 |
| Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline SS Chang, SA Boorjian, R Chou, PE Clark, S Daneshmand, BR Konety, ... The Journal of urology 196 (4), 1021-1029, 2016 | 1429 | 2016 |
| Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial DJ Parekh, IM Reis, EP Castle, ML Gonzalgo, ME Woods, RS Svatek, ... The Lancet 391 (10139), 2525-2536, 2018 | 768 | 2018 |
| Active surveillance for the management of prostate cancer in a contemporary cohort MA Dall'Era, BR Konety, JE Cowan, K Shinohara, F Stauf, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 472 | 2008 |
| Oral relugolix for androgen-deprivation therapy in advanced prostate cancer ND Shore, F Saad, MS Cookson, DJ George, DR Saltzstein, R Tutrone, ... New England Journal of Medicine 382 (23), 2187-2196, 2020 | 426 | 2020 |
| Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study AV Balar, AM Kamat, GS Kulkarni, EM Uchio, JL Boormans, M Roumiguié, ... The Lancet Oncology 22 (7), 919-930, 2021 | 420 | 2021 |
| Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results … BR Konety, SA Joslyn, MA O’DONNELL The Journal of urology 169 (3), 946-950, 2003 | 399 | 2003 |
| Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer SA Joslyn, BR Konety Urology 68 (1), 121-125, 2006 | 381 | 2006 |
| Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial SA Boorjian, M Alemozaffar, BR Konety, ND Shore, LG Gomella, ... The Lancet Oncology 22 (1), 107-117, 2021 | 378 | 2021 |
| Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes PK Agarwal, N Sadetsky, BR Konety, MI Resnick, PR Carroll Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 369 | 2008 |
| Recurrence of high‐risk bladder cancer: a population‐based analysis K Chamie, MS Litwin, JC Bassett, TJ Daskivich, J Lai, JM Hanley, ... Cancer 119 (17), 3219-3227, 2013 | 368 | 2013 |
| PSA screening among elderly men with limited life expectancies LC Walter, D Bertenthal, K Lindquist, BR Konety Jama 296 (19), 2336-2342, 2006 | 322 | 2006 |
| Complications after radical cystectomy: analysis of population-based data BR Konety, V Allareddy, H Herr Urology 68 (1), 58-64, 2006 | 318 | 2006 |
| Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy J Kurhanewicz, DB Vigneron, SJ Nelson, H Hricak, JM MacDonald, ... Urology 45 (3), 459-466, 1995 | 298 | 1995 |
| Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system RH Getzenberg, BW Light, PE Lapco, BR Konety, AK Nangia, JS Acierno, ... Urology 50 (6), 999-1006, 1997 | 291 | 1997 |
| Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway S Urakami, H Shiina, H Enokida, T Kawakami, T Tokizane, T Ogishima, ... Clinical Cancer Research 12 (2), 383-391, 2006 | 264 | 2006 |
| Bladder cancer-associated nuclear matrix proteins RH Getzenberg, BR Konety, TA Oeler, MM Quigley, A Hakam, MJ Becich, ... Cancer Research 56 (7), 1690-1694, 1996 | 254 | 1996 |
| Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project BR Konety, V Dhawan, V Allareddy, SA Joslyn The Journal of urology 173 (5), 1695-1700, 2005 | 228 | 2005 |
| Urine based markers of urological malignancy BR Konety, RH Getzenberg The Journal of urology 165 (2), 600-611, 2001 | 227 | 2001 |
| High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey CH Bunker, AL Patrick, BR Konety, R Dhir, AM Brufsky, CA Vivas, ... Cancer Epidemiology Biomarkers & Prevention 11 (8), 726-729, 2002 | 213 | 2002 |
